The treatment of hypopigmentation in children

Clinics in Dermatology

Volumn 21, Issue 4, 2003, Pages 296-310

  Schaffer, Julie V ^a   Bolognia, Jean L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; IMMUNOMODULATING AGENT; METHOXALEN; METHOXSALEN; TACROLIMUS; TRIOXYSALEN; UNCLASSIFIED DRUG; XIPAMIDE;

ACNE; BULLOUS SKIN DISEASE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPIGMENTATION; DRUG COST; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ERYTHEMA; FATIGUE; HUMAN; HYPERTRICHOSIS; HYPOPIGMENTATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSOMNIA; INTRAOCULAR PRESSURE ABNORMALITY; NAUSEA; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN GRAFT; SKIN PIGMENTATION; SKIN TRANSPLANTATION; STRIA; SYSTEMIC DISEASE; TELANGIECTASIA; ULTRAVIOLET B RADIATION; VITILIGO; VOMITING; WEIGHT GAIN;

EID: 0142187116     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(03)00045-2     Document Type: Article

References (96)

1. Lerner A.B. Vitiligo. J Invest Dermatol. 32:1959;285-310.
2. Halder R.M., Grimes P.E., Cowan C.A., et al. Childhood vitiligo. J Am Acad Dermatol. 16:1987;948-954.
3. Cho S., Kang H.-C., Hahm J.-H. Characteristics of vitiligo in Korean children. Pediatr Dermatol. 17:2000;189-193.
4. Kovacs S.O. Vitiligo. J Am Acad Dermatol. 38:1998;66-67.
5. Cui J., Shen L.Y., Wang G.C. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 97:1991;410-416.
6. van den Wijngaard R., Wankowicz-Kalinska A., Pals S., et al. Autoimmune melanocyte destruction in vitiligo. Lab Invest. 81:2001;1061-1067.
7. Gokhale B.B., Mehta L.N. Histopathology of vitiliginous skin. Int J Dermatol. 22:1983;477-480.
8. van den Wijngaard R., Wankowicz-Kalinska A., Le Poole C., et al. Local immune response in skin of generalized vitiligo patients destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site . Lab Invest. 80:2000;1299-1309.
9. Bolognia J.L. Therapeutics in pigmentary disorders medical, surgical and physical approaches . Levine N. Pigmentation and pigmentary disorders. 1993;502-507 CRC Press Inc, Boca Raton, Fla.
10. Koga M. Vitiligo a new classification and therapy . Br J Dermatol. 97:1977;255-261.
11. Kumari J. Vitiligo treated with topical clobetasol propionate. Arch Dermatol. 120:1984;631-635.
12. Liu X.Q., Shao C.G., Jin P.Y., et al. Treatment of localized vitiligo with ulobetasol cream. Int J Dermatol. 29:1990;295-297.
13. Khalid M., Mujtaba G., Haroon T.S. Comparison of 0.05% clobetasol propionate cream and topical PUVASOL in childhood vitiligo. Int J Dermatol. 34:1995;203-205.
14. Halder R.M., Brooks H.L. Medical therapies for vitiligo. Dermatol Ther. 14:2001;1-6.
15. Njoo M.D., Spuls P.I., Bos J.D., et al. Nonsurgical repigmentation therapies in vitiligo. Arch Dermatol. 134:1998;1532-1540.
16. Njoo M.D., Das P.K., Bos J.D., et al. Association of the Köebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 135:1999;407-413.
17. Njoo M.D., Westerhof W. Guidelines for treatment of vitiligo is an update pending if recommendations for children are not followed?: in reply. Arch Dermatol. 136:2000;1173-1174.
18. Scherschun L., Kim J.J., Lim H.W. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol. 44:2001;999-1003.
19. Khalid M., Mujtaba G. Response of segmental vitiligo to 0.05% clobetasol propionate cream. Int J Dermatol. 37:1998;705-708.
20. Grimes P.E. Vitiligo an overview of therapeutic approaches . Dermatol Clin. 11:1993;325-338.
21. Morelli J.G. Vitiligo in children treatment options . Dermatol Ther. 2:1997;93-97.
22. Seiter S., Ugurel S., Tilgen W., et al. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo. Int J Dermatol. 39:2000;624-627.
23. Radakovic-Fijan S., Furnsinn-Friedl A.M., Honigsmann H., et al. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol. 44:2001;814-817.
24. Lepe V., Moncada B., Castanedo-Cazares J.P., et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 139:2003;581-585.
25. El Mofty A.M. A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn. J Egypt Med Assoc. 31:1948;651-660.
26. Parrish J.A., Fitzpatrick T.B., Shea C., et al. Photochemotherapy of vitiligo use of orally administered psoralens and a high-intensity long-wave ultraviolet light system . Arch Dermatol. 112:1976;1531-1534.
27. van Weelden H., De La Faille H.B., Young E., et al. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 119:1988;11-19.
28. Westerhof W., Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol. 133:1997;1525-1528.
29. Morelli J.G., Kincannon J., Yohn J.J., et al. Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol. 98:1992;290-295.
30. Archambault M., Yaar M., Gilchrest B.A. Keratinocytes and fibroblasts in a human skin equivalent model enhance melanocyte survival and melanin synthesis after ultraviolet irradiation. J Invest Dermatol. 104:1995;859-867.
31. Imokawa G., Miyagishi M., Yada Y. Endothelin-1 as a new melanogen coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis . J Invest Dermatol. 105:1995;32-37.
32. Horikawa T., Norris D.A., Johnson T.W., et al. DOPA-negative melanocytes in the outer root sheath of human hair follicles are positive for premelanosomal antigens, but negative for a melanosomal antigen or melanosome associated glycoproteins, tyrosinase, TRP-1 and TRP-2. J Invest Dermatol. 106:1996;28-35.
33. Abdel-Naser M.B., Hann S.-K., Bystryn J.-C. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation. Arch Dermatol. 133:1997;1530-1533.
34. Fitzpatrick T.B. Mechanisms of phototherapy of vitiligo. Arch Dermatol. 133:1997;591-592.
35. Westerhof W., Nieuweboer-Krobotova L., Mulder P.G., et al. Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch Dermatol. 135:1999;1061-1066.
36. Pathak M.A., Mosher D.B., Fitzpatrick T.B. Safety and therapeutic effectiveness of 8- methoxypsoralen, 4,5′,8-trimethylpsoralen, and psoralen in vitiligo. Natl Cancer Inst Monogr. 66:1984;165-173.
37. Le Poole C., Boissy R.E. Vitiligo. Sem Cutan Med Surg. 16:1997;3-14.
38. Grimes P.E. Psoralen photochemotherapy for vitiligo. Clin Dermatol. 15:1997;921-926.
39. Grimes P.E., Minus H.R., Halder R.M., et al. Vitiligo racial variations in the response to topical photochemotherapy . J Invest Dermatol. 80:1983;367.
40. Kenney J.A. Jr. Vitiligo treated by psoralens a long-term follow-up study of the permanency of repigmentation . Arch Dermatol. 103:1971;475-480.
41. Theodoridis A., Tsambaos D., Sivenas C., et al. Oral trimethylpsoralen in the treatment of vitiligo. Acta Dermatol Venereol. 56:1976;253.
42. Zaynoun S., Jaber L.A., Kurban A.K. Oral methoxypsoralen photochemotherapy of extensive pityriasis alba preliminary report . J Am Acad Dermatol. 15:1986;61-65.
43. Hayashibe K., Mishima Y. Tyrosinase-positive melanocyte distribution and induction of pigmentation in human piebald skin. Arch Dermatol. 124:1988;381-386.
44. Drake L.A., Dinehart S.M., Farmer E.R., et al. Guidelines for care of vitiligo. J Am Acad Dermatol. 35:1996;620-626.
45. Grimes P.E., Minus H.R., Chakrabarti S., et al. Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol. 7:1982;771-778.
46. Antoniou C., Katsambas A. Guidelines for the treatment of vitiligo. Drugs. 43:1992;490-498.
47. Grimes P.E., Kelly A.P., Cline D.J., et al. Management of vitiligo in children (a symposium). Pediatr Dermatol. 3:1986;498-510.
48. Njoo M.D., Westerhof W., Bos J.D., et al. The development of guidelines for the treatment of vitiligo. Arch Dermatol. 135:1999;1514-1521.
49. Takeda H., Mitsuhashi Y., Kondo S. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol. 38:1998;268-270.
50. Ortel B., Tanew A., Honigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol. 18:1988;693-701.
51. Njoo M.D., Bos J.D., Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 42:2000;243-245.
52. Camacho F., Mazuecos J. Treatment of vitiligo with oral and topical phenylalanine 6 years of experience . Arch Dermatol. 135:1999;216-217.
53. Schallreuter K.U., Zxchiesche M., Moore J., et al. In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun. 243:1998;395-399.
54. Schallreuter K.U., Wood J.M., Lemke K.R., et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure a case study on 33 patients . Dermatology. 190:1995;223-229.
55. 4-dependent processes? J Invest Dermatol. 116:2001;167-174.
56. Parsad D., Saini R., Verma N. Combination of PUVASOL and topical calcipotriol in vitiligo. Dermatology. 197:1998;167-170.
57. Ermis O., Alpsoy E., Cetin L., et al. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? a placebo-controlled double-blind study. Br J Dermatol. 145:2001;472-475.
58. Parsad D., Saini R., Nagpal R. Calcipotriol in vitiligo a preliminary study . Pediatr Dermatol. 16:1999;317-320.
59. Ameen M., Exarchou V., Chu A.C. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol. 145:2001;476-479.
60. Falabella R. Repigmentation of stable leukoderma by autologous minigrafting. J Dermatol Surg Oncol. 12:1986;172-179.
61. Falabella R., Barona M.I., Escobar C., et al. Surgical combination therapy for vitiligo and piebaldism. Dermatol Surg. 21:1995;852-857.
62. Olsson M.J., Juhlin L. Transplantation of melanocytes in vitiligo. Br J Dermatol. 132:1995;587-591.
63. Njoo M.D., Nieuweboer-Krobotova L., Westerhof W. Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin split-thickness skin grafting in combination with minigrafting. Br J Dermatol. 139:1998;829-833.
64. Malakar S., Lahiri K., Malakar R. How unstable is the concept of stability in surgical repigmentation of vitiligo? Dermatology. 201:2000;182-183.
65. Hatchome N., Kato T., Tagami H. Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon. J Am Acad Dermatol. 22:1990;87-91.
66. Boersma B.R., Westerhof W., Bos J.D. Repigmentation in vitiligo vulgaris by autologous minigrafting results in nineteen patients . J Am Acad Dermatol. 33:1995;990-995.
67. Kim H.Y., Kang K.Y. Epidermal grafts for treatment of stable and progressive vitiligo. J Am Acad Dermatol. 40:1999;412-417.
68. Kumar A.S., Sarin R.C., Puri V.K. Evaluation of replacement graft and punch grafts in the treatment of vitiligo. Ind J Dermatol Venereol Leprol. 46:1980;140-145.
69. Malakar S., Dhar S. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting a prospective study of 1,000 patients . Dermatology. 198:1999;133-139.
70. Halder R.M., Young C.M. New and emerging therapies for vitiligo. Dermatol Clin. 18:2000;79-89.
71. McGovern T., Leffell D. Surgical therapies, part II flip-top transplants in vitiligo . Dermatol Ther. 14:2001;15-19.
72. Leachman S. Surgical therapies, part III melanocyte transplants . Dermatol Ther. 14:2001;20-28.
73. Savant S.S. Autologous miniature punch skin grafting in stable vitiligo. Ind J Dermatol Venereol Leprol. 58:1992;310-314.
74. Mutalik S., Ginzburg A. Surgical management of stable vitiligo a review with personal experience . Dermatol Surg. 26:2000;248-254.
75. Falabella R. Surgical therapies for vitiligo and other leukodermas, part I minigrafting and suction epidermal grafting . Dermatol Ther. 14:2001;7-14.
76. Falabella R., Arrunategui A., Barona M.I., et al. The minigrafting test for vitiligo detection of stable lesions for melanocyte transplantation: reply . J Am Acad Dermatol. 33:1995;1061-1062.
77. Falabella R., Arrunategui A., Barona M.I., et al. The minigrafting test for vitiligo detection of stable lesions for melanocyte transplantation . J Am Acad Dermatol. 32:1995;228-232.
78. Westerhof W., Boersma B. The minigrafting test for vitiligo detection of stable lesions for melanocyte transplantation . J Am Acad Dermatol. 33:1995;1061-1062.
79. Njoo M.D., Westerhof W., Bos J.D., et al. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol. 134:1998;1543-1549.
80. Yaar M., Gilchrest B.A. Vitiligo the evolution of cultured epidermal autografts and other surgical treatment modalities . Arch Dermatol. 137:2001;348-349.
81. Lerner A.B., Halaban R., Klaus S.N., et al. Transplantation of human melanocytes. J Invest Dermatol. 89:1987;219-224.
82. Brysk M., Newton R.C., Rajaraman S., et al. Repigmentation of vitiliginous skin by cultured cells. Pigment Cell Res. 2:1989;202-207.
83. Falabella R. Surgical therapies for vitiligo. Clin Dermatol. 15:1997;927-939.
84. Guerra L., Capurro S., Melchi F., et al. Treatment of "stable" vitiligo by timed surgery and transplantation of cultured epidermal autografts. Arch Dermatol. 136:2000;1380-1389.
85. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol. 50:1968;129-137.
86. McGovern T.W., Bolognia J.L., Leffell D.J. Flip-top pigment transplantation a novel transplantation procedure for the treatment of depigmentation . Arch Dermatol. 135:1999;1305-1307.
87. Na G.Y., Seo S.K., Choi S.K. Single hair grafting for the treatment of vitiligo. J Am Acad Dermatol. 38:1998;580-584.
88. Falabella R., Escobar C., Borrero I. Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes. J Am Acad Dermatol. 26:1992;230-236.
89. Hann S.K., Im S., Park Y.K., et al. Repigmentation of leukotrichia by epidermal grafting and systemic psoralen plus UVA. Arch Dermatol. 128:1992;998-999.
90. Agrawal K., Agrawal A. Vitiligo surgical repigmentation of leukotrichia . Dermatol Surg. 21:1995;711-715.
91. Hann S.K., Im S., Bong H.W., et al. Treatment of stable vitiligo with autologous epidermal grafting and PUVA. J Am Acad Dermatol. 32:1995;943-948.
92. Skouge J., Morison W.L. Vitiligo treatment with a combination of PUVA therapy and epidermal autografts. Arch Dermatol. 131:1995;1257-1258.
93. Gauthier Y., Surleve-Bazeille J.E. Autologous grafting with noncultured melanocytes a simplified method for treatment of depigmented lesions . J Am Acad Dermatol. 26:1992;191-194.
94. Levy S.B. Tanning preparations. Dermatol Clin. 18:2000;591-596.
95. Bolognia J.L., Lapia K., Somma S. Depigmentation therapy. Dermatol Ther. 14:2001;29-34.
96. Njoo M.D., Vodegel R.M., Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol. 42:2000;760-769.